HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Supplemental Data All Versions of this Article: 2006-0773v1 25/9/2302    most recent Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints/Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Pollett, J. B. Articles by Huard, J. Search for Related Content PubMed PubMed Citation Articles by Pollett, J. B. Articles by Huard, J.

TISSUE-SPECIFIC STEM CELLS

Malignant Transformation of Multipotent Muscle-Derived Cells by Concurrent Differentiation Signals

^aStem Cell Research Center, Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, USA;
^bUniversity of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania, USA;
Departments of ^cOrthopaedic Surgery,
^dBioengineering,
^ePlastic Surgery, and
^fMolecular Genetics and Biochemistry, University of Pittsburgh, Pittsburgh, Pennsylvania, USA

Key Words. Muscle stem cells • Differentiation • Environment • Transformation

Correspondence: Johnny Huard, Ph.D., Stem Cell Research Center, 4100 Rangos Research Center, 3460 Fifth Avenue, Pittsburgh, Pennsylvania 15213, USA. Telephone: 412-692-7807; Fax: 412-692-7095; e-mail: jhuard{at}pitt.edu

Received December 1, 2006; accepted for publication May 30, 2007.
First published online in STEM CELLS EXPRESS   June 14, 2007.



Recent studies have shown that germ-line determination occurs early in development and that extracellular signaling can alter this fate. This denial of a cell's fate by counteracting its intrinsic signaling pathways through extrinsic stimulation is believed to be associated with oncogenesis. Using specific populations of multipotent skeletal muscle-derived stem cells (MDSCs), we have been able to generate tumors by subjecting cells with specific lineage predilections to concomitant differentiation signals. More specifically, when a stem cell that had a predilection toward osteogenesis was implanted into a skeletal muscle, tumors formed in 25% of implanted mice. When cells predilected to undergo myogenesis were pretreated with bone morphogenetic protein 4 (BMP4) for 4 days prior to implantation, they formed tumors in 25% of mice. These same myogenic predilected cells, when transduced to express BMP4 and implanted into either a long-bone or cranial defect, formed bone, but they formed tumors in 100% of mice when implanted into the skeletal muscle. The tumors generated in this latter study were serially transplantable as long as they retained BMP4 expression. Furthermore, when we impeded the ability of the cells to undergo myogenic differentiation using small interfering RNA to the myogenic regulator MyoD1, we stopped transformation. Based on our findings, we postulate that specific MDSC populations can undergo concomitant signal-induced transformation and that the initial stages of transformation may be due to changes in the balance between the inherent nature of the cell and extrinsic signaling pathways. This theory represents a potential link between somatic stem cells and cancer and suggests an involvement of the niche/environment in transformation.

Disclosure of potential conflicts of interest is found at the end of this article.